Truveris, a Wilmington, DE-based company which specializes in pharmacy cost containment and program performance, raised $15M in Series E funding.
The round was led by two lead investors, Canaan Partners and New Leaf Venture Partners.
The company intends to use the funds to support its next stage of corporate development and operational growth across employers nationwide.
Led by CEO Nanette Oddo, Truveris is a healthcare technology company that is focused on reducing pharmacy spend. It has built an independent, data-led, tech platform that creates complete PBM pricing transparency and drives competition to reduce costs for employers. Its solutions replace traditional pharmacy procurement and renewal models for self-insured employers by providing deep insights, comparative procurement, 100% claims analysis, and member engagement solutions.
Commenting on the news, Nanette Oddo said: “This financing round represents a further validation of our industry-leading solutions and ongoing growth potential. We will continue to evolve the Truveris platform, and together with our valued business partners and clients, will transform and reduce pharmacy spend for employers and their plan members.”
